Literature DB >> 14673616

Lifestyle issues and genitourinary tumours.

Frank Sommer1, Theo Klotz, Bernd J Schmitz-Dräger.   

Abstract

A variety of lifestyle factors, including physical activity, artificial sweeteners, alcohol consumption and smoking, have been reported to contribute to the risk of developing urological malignancies. A great number of epidemiological studies suggest that sports and physical activity may have a preventive influence on genitourinary tumours, especially on the incidence of prostate cancer. Smoking appears to be the most relevant lifestyle factor significantly increasing both incidence and mortality from bladder cancer. Furthermore, there is evidence implicating an association between tobacco use and kidney cancer. In contrast, prostate and testicular cancers are unlikely to be linked to tobacco use. As far as alcohol is concerned, most studies indicate that neither amount nor type of alcohol seems to be clearly associated with a risk of developing urological malignancies. However, some more recent cohort studies suggest a moderately increased risk for prostate and bladder cancer for specific types of alcohol. On the other hand, there is evidence that moderate alcohol consumption may even protect women from developing renal cancer. Since the introduction of artificial sweeteners, reports of potential cancer risks have circulated periodically through the mass media. The wide distribution of these agents and the fact that mostly combinations of the different compounds are added to a broad variety of food, drinks, drugs, and hygiene products complicates a systematic analysis of their potential impact on the development of urological malignancies. Nevertheless, so far not a single study has convincingly demonstrated a statistically significant risk of bladder cancer due to the consumption of artificial sweeteners. This survey demonstrates that the individual assessment of lifestyle factors not only may identify groups with an increased risk for urological malignancies but also clearly displays a potential for tumour prevention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14673616     DOI: 10.1007/s00345-003-0379-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  82 in total

Review 1.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

2.  The pharmacokinetics and tissue concentrations of cyclohexylamine in rats and mice.

Authors:  A Roberts; A G Renwick
Journal:  Toxicol Appl Pharmacol       Date:  1989-04       Impact factor: 4.219

3.  Tobacco and cancer, the European perspective.

Authors:  P Boyle
Journal:  Ann Oncol       Date:  1995-05       Impact factor: 32.976

4.  Risk factors for cancer of the testis in young men.

Authors:  B E Henderson; B Benton; J Jing; M C Yu; M C Pike
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

5.  Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study.

Authors:  A W Hsing; J K McLaughlin; L M Schuman; E Bjelke; G Gridley; S Wacholder; H T Chien; W J Blot
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

6.  Cigar smoking in men and risk of death from tobacco-related cancers.

Authors:  J A Shapiro; E J Jacobs; M J Thun
Journal:  J Natl Cancer Inst       Date:  2000-02-16       Impact factor: 13.506

7.  Fluid consumption and the risk of bladder cancer: results of a multicenter case-control study.

Authors:  B Geoffroy-Perez; S Cordier
Journal:  Int J Cancer       Date:  2001-09       Impact factor: 7.396

Review 8.  Tobacco industry strategies for influencing European Community tobacco advertising legislation.

Authors:  Mark Neuman; Asaf Bitton; Stanton Glantz
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

9.  A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands).

Authors:  Maurice P A Zeegers; R Alexandra Goldbohm; Piet A van den Brandt
Journal:  Cancer Causes Control       Date:  2002-02       Impact factor: 2.506

10.  Risk factors for renal cell carcinoma in Denmark. I. Role of socioeconomic status, tobacco use, beverages, and family history.

Authors:  A Mellemgaard; G Engholm; J K McLaughlin; J H Olsen
Journal:  Cancer Causes Control       Date:  1994-03       Impact factor: 2.506

View more
  6 in total

1.  Predictive medicine in urology.

Authors:  Bernd J Schmitz-Dräger; Nuria Malats; Pierfrancesco Bassi
Journal:  World J Urol       Date:  2003-12-18       Impact factor: 4.226

Review 2.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

3.  Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions.

Authors:  Dante D Cáceres; Jeannette Iturrieta; Cristian Acevedo; Christian Huidobro; Nelson Varela; Luis Quiñones
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Shared occupational risks for transitional cell cancer of the bladder and renal pelvis among men and women in Sweden.

Authors:  Robin Taylor Wilson; Mark Donahue; Gloria Gridley; Johanna Adami; Laure El Ghormli; Mustafa Dosemeci
Journal:  Am J Ind Med       Date:  2008-02       Impact factor: 2.214

5.  [The causes of urinary bladder cancer and possibilities of prevention].

Authors:  K Golka; A W Rettenmeier; P J Goebell
Journal:  Urologe A       Date:  2006-03       Impact factor: 0.639

6.  Increased risk for urological cancer associated with anxiety disorder: a retrospective cohort study.

Authors:  Yung-Chan Chen; Li-Ting Kao; Herng-Ching Lin; Hsin-Chien Lee; Chung-Chien Huang; Shiu-Dong Chung
Journal:  BMC Urol       Date:  2016-11-16       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.